Instituto Nacional de Cancerología (INCan), Mexico City, México.
World J Surg Oncol. 2009 Dec 17;7:97. doi: 10.1186/1477-7819-7-97.
Germ-line mutations of the TP53 gene are known to cause Li-Fraumeni syndrome, an autosomal, dominantly inherited, high-penetrance cancer-predisposition syndrome characterized by the occurrence of a variety of cancers, mainly soft tissue sarcomas, adrenocortical carcinoma, leukemia, breast cancer, and brain tumors.
Mutation analysis was based on Denaturing high performance liquid chromatography (DHPLC) screening of exons 2-11 of the TP53 gene, sequencing, and cloning of DNA obtained from peripheral blood lymphocytes.
We report herein on Li Fraumeni syndrome in a family whose members are carriers of a novel TP53 gene mutation at exon 4. The mutation comprises an insertion/duplication of seven nucleotides affecting codon 110 and generating a new nucleotide sequence and a premature stop codon at position 150. With this mutation, the p53 protein that should be translated lacks the majority of the DNA binding domain.
To our knowledge, this specific alteration has not been reported previously, but we believe it is the cause of the Li-Fraumeni syndrome in this family.
TP53 基因的种系突变已知会导致李-佛美尼综合征,这是一种常染色体显性遗传、高外显率的癌症易感性综合征,其特征是发生多种癌症,主要是软组织肉瘤、肾上腺皮质癌、白血病、乳腺癌和脑肿瘤。
突变分析基于对 TP53 基因外显子 2-11 的变性高效液相色谱(DHPLC)筛选、测序和从外周血淋巴细胞中获得的 DNA 克隆。
我们在此报告了一个家族的李-佛美尼综合征,该家族成员携带有 TP53 基因外显子 4 的新型突变。该突变包括影响密码子 110 的七个核苷酸的插入/重复,并在 150 位产生新的核苷酸序列和一个提前终止密码子。由于这个突变,应该被翻译的 p53 蛋白缺少大部分 DNA 结合域。
据我们所知,这种特定的改变以前没有报道过,但我们认为它是这个家族李-佛美尼综合征的原因。